Concordance of HER2 status assessed on needle core biopsy and surgical specimens of invasive carcinoma of the breast
Author:
Publisher
Wiley
Subject
General Medicine,Histology,Pathology and Forensic Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2559.2011.04144.x/fullpdf
Reference13 articles.
1. HER2 testing in the UK: further update to recommendations;Walker;J. Clin. Pathol.,2008
2. Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC);Arnedos;Ann. Oncol.,2009
3. Breast carcinomas with borderline (2+) HER2 immunohistochemistry: the percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification;Lee;J. Clin. Pathol.,2011
4. Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer;Apple;Mod. Pathol.,2009
5. Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed;D’Alfonso;Am. J. Surg. Pathol.,2010
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HER2‐positive grade 1 invasive carcinomas of the breast;Histopathology;2024-09-11
2. Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice points and challenges;Histopathology;2024-06-06
3. Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status;Breast Cancer;2024-04-21
4. Should a borderline negative HER2 result in a core biopsy of invasive carcinoma of the breast have HER2 assessment repeated in the excision specimen?;Journal of Clinical Pathology;2023-08-30
5. Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature;Breast Cancer Research and Treatment;2023-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3